Table 1.
Weight variables and cardiometabolic risk factors of the study cohort
| Mean | SD | Minimum | 25th percentile | Median | 75th percentile | Maximum | |
|---|---|---|---|---|---|---|---|
| Baseline | |||||||
| Fasting glucose (mg/dL) | 106.27 | 8.15 | 76.00 | 100.00 | 105.00 | 112.00 | 139.00 |
| HOMA-IR | 6.99 | 4.33 | 0.56 | 4.15 | 6.05 | 8.89 | 54.46 |
| Triglyceride (mg/dL) | 163.42 | 97.38 | 31.00 | 98.00 | 139.00 | 198.00 | 796.00 |
| SBP (mmHg) | 123.42 | 14.63 | 84.00 | 112.00 | 122.00 | 132.00 | 175.00 |
| At year 2 | |||||||
| Fasting glucose (mg/dL) | 104.92 | 14.78 | 74.00 | 97.00 | 103.00 | 110.00 | 331.00 |
| HOMA-IR | 5.97 | 4.67 | 0.46 | 3.20 | 4.87 | 7.31 | 60.03 |
| Triglyceride (mg/dL) | 140.95 | 84.00 | 31.00 | 86.00 | 118.00 | 169.00 | 672.00 |
| SBP (mmHg) | 120.12 | 14.72 | 84.00 | 110.00 | 119.00 | 129.00 | 209.00 |
| Baseline weight (kg) | 93.70 | 20.29 | 48.60 | 79.00 | 90.90 | 104.58 | 192.20 |
| Weight loss from baseline to (kg) | |||||||
| 1 month | 1.38 | 2.66 | −17.17 | −0.18 | 1.27 | 2.83 | 15.85 |
| 3 months | 4.40 | 3.87 | −9.62 | 1.79 | 4.13 | 6.51 | 25.27 |
| 6 months | 6.84 | 5.62 | −13.25 | 3.20 | 6.45 | 9.60 | 35.55 |
| 2 years | 5.39 | 7.56 | −19.15 | 1.05 | 4.50 | 8.50 | 77.50 |
| Weight loss from (kg) | |||||||
| 18 months to 2 years | −1.38 | 5.73 | −27.60 | −4.35 | −1.20 | 1.13 | 49.20 |
| 6 months to 2 years | −0.61 | 3.18 | −17.95 | −2.25 | −0.60 | 0.90 | 33.60 |
| 5-lb weight cycles (n) | 1.45 | 0.99 | 0 | 1 | 1 | 2 | 6 |
| Average weight (kg) | 83.03 | 19.87 | 44.93 | 74.02 | 84.57 | 98.66 | 188.68 |
All body composition variables are raw weight loss values in the units of kilograms. The study sample consisted of 1,000 intensive lifestyle participants with at least 2 years of follow-up and excluded participants who developed diabetes during those 2 years (n = 952).